ASCLF:OTC-Ascletis Pharma Inc (USD)

COMMON STOCK | Others | OTC

Last Closing Price

USD 0.54

Change

0.00 (0.00)%

Market Cap

N/A

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

Ascletis Pharma Inc (ASCLF) Stock Analysis:
Based on the Ascletis Pharma Inc stock forecasts from 0 analysts, the average analyst target price for Ascletis Pharma Inc is not available over the next 12 months. Ascletis Pharma Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Ascletis Pharma Inc is Very Bearish, which is based on 0 positive signals and 2 negative signals. At the last closing, Ascletis Pharma Inc’s stock price was USD 0.54. Ascletis Pharma Inc’s stock price has changed by +0.00% over the past week, -21.00% over the past month and +134,125.00% over the last year.

No recent analyst target price found for Ascletis Pharma Inc
No recent average analyst rating found for Ascletis Pharma Inc

About

Currency: N/A

Country : N/A

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CSTNL iShares VII Public Limited Com..

-11.90 (-2.83%)

 USD32.85B 19.50 N/A
DAXXF iShares Core DAX UCITS ETF (DE..

N/A

 USD22.34B N/A N/A
IISHF iShares III Public Limited Com..

N/A

 USD9.10B N/A N/A
ZKBGF ZKB Gold ETF

N/A

 USD8.96B N/A N/A
IHPCF iShares Public Limited Company..

N/A

 USD8.93B 19.50 N/A
CUYTF Etn. Fr. Colruyt NV

N/A

 USD8.61B 20.58 10.33
TOETF Tosei Corporation

N/A

 USD7.70B 151.60 -597.40
CUYTY Etn. Fr. Colruyt NV

-0.77 (-8.69%)

 USD7.56B 15.26 10.33
EFMSF ETFS Metal Securities Limited ..

N/A

 USD7.39B N/A N/A
IUTSF iShares S&P/TSX 60 Index ETF

N/A

 USD6.41B N/A N/A

ETFs Containing ASCLF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Others)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10,638.00% 100% A+ 100% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10,638.00% 100% A+ 100% A+
Trailing 12 Months  
Capital Gain N/A 100% A+ 100% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A 100% A+ 100% A+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 120.03% 94% A 82% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 120.03% 94% A 82% B-
Risk Return Profile  
Volatility (Standard Deviation) 4,462.16% 2% F 4% F
Risk Adjusted Return 2.69% 48% F 28% F
Market Capitalization N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Others)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A N/A N/A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials ()

Quarterly Financials ()

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.